Related Experiment Video
Updated: Apr 5, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3.
The updated Good Publication Practice (GPP3) guideline offers recommendations for ethical and transparent publication of company-sponsored research. It ensures integrity and accountability in reporting medical research findings.
Area of Science:
- Medical Publication
- Scientific Communication
- Biopharmaceutical Industry
Background:
- Previous Good Publication Practice (GPP) guidelines required updates to reflect current practices.
- Industry-sponsored research necessitates clear ethical and transparent reporting standards.
Framework:
- The GPP3 guideline provides comprehensive recommendations for publishing company-sponsored research.
- It covers peer-reviewed journal publications and scientific congress presentations.
Implementation:
- Developed through a global consensus involving over 3000 professionals and a 18-member steering committee.
- Incorporated feedback from 94 reviewers on the second draft to refine recommendations.
Implications:
- Enhances integrity, accountability, and transparency in reporting medical research.
- Provides updated guidance on authorship, data sharing, plagiarism, and the role of medical writers.
More Related Videos
05:34Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure
Published on: December 13, 2024
09:36Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures
Published on: October 3, 2016
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview
Bioavailability Study Design: Healthy Subjects Versus Patients
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Trials: Overview
Methods of Documentation II: POMR